Wellstone in Conference Call With FDA

* Reuters is not responsible for the content in this press release.

Mon Nov 2, 2009 12:29pm EST

CHAPEL HILL, N.C.--(Business Wire)--
Wellstone Filters Sciences, Inc. (OTC Bulletin Board: WFSN), the leading
modified risk cigarette filter company, is pleased to announce that it
participated in the FDA's conference call regarding the guidance document
entitled "Registration and Product Listing for Owners and Operators of Domestic
Tobacco Product Establishments." 

During the conference call, Wellstone's CEO L.J. Hand focused on the need for
clarification of registration by companies such as Wellstone who participate in
only part of the manufacturing process. Wellstone is a filter technology company
dedicated to research, discovery and development of methods and compounds that
remove a wide range of toxins and carcinogens without impairing consumer
acceptance. 

ABOUT THE COMPANY

Wellstone Filter Sciences, Inc., Inc. has developed and patented a "Reduced
Exposure Product," or "REP," cigarette filter that reduces toxins and
carcinogens without compromising taste. With over a decade of research and
development, Wellstone is the only company specializing in Reduced Filter
Products poised for new FDA oversight of Tobacco products. 

Wellstone's filter technology has undergone several tests for efficacy including
official FTC testing. Wellstone CEO L.J. Hand stated, "We are by far, the best
available technology in the highly specialized field of REP technology. " 

The Wellstone Filter does not affect taste -- clinical trials have shown that
the filter can actually enhance taste by removing irritating compounds such as
ammonia. Further, the cost of the patented filter is not prohibitive; Wellstone
has developed a low-cost manufacturing process which will have little impact on
the cost of the final product. 

Note: This News Release may contain forward-looking statements that involve
substantial risks and uncertainties. Among the factors that could cause actual
results or timelines to differ materially are risks associated with research and
clinical development, regulatory approvals, supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation,
and the other risk factors listed from time to time in reports filed by
Wellstone with the Securities and Exchange Commission. The forward-looking
statements contained in this news release represent judgments of the management
of Wellstone as of the date of this release. 

Wellstone Filters can be found online at http://www.Wellstonefilter.com and
http://www.wellstone-filters.com/.

Wellstone Filter Sciences, Inc.
John Wilson, 919-370-4408 



Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.